Literature DB >> 24323393

Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients.

Fernanda Genre1, Raquel López-Mejías, José A Miranda-Filloy, Begoña Ubilla, Beatriz Carnero-López, Inés Gómez-Acebo, Ricardo Blanco, Rodrigo Ochoa, Javier Rueda-Gotor, Trinitario Pina, Carlos González-Juanatey, Javier Llorca, Miguel A González-Gay.   

Abstract

Entities:  

Keywords:  Ankylosing Spondylitis; Anti-TNF; Atherosclerosis; Inflammation

Mesh：

Substances：

Year:  2013        PMID： 24323393     DOI： 10.1136/annrheumdis-2013-204484

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

Review 1.  Metabolic syndrome and chronic arthritis: effects of anti-TNF-α therapy.

Authors:  Nicola Maruotti; Francesca d'Onofrio; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2014-11-27       Impact factor: 3.984

2.  Adipokine role in physiopathology of inflammatory and degenerative musculoskeletal diseases.

Authors:  Liberato Giardullo; Addolorata Corrado; Nicola Maruotti; Daniela Cici; Natalia Mansueto; Francesco Paolo Cantatore
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

Review 3.  Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis.

Authors:  Fernanda Genre; Raquel López-Mejías; José A Miranda-Filloy; Begoña Ubilla; Beatriz Carnero-López; Ricardo Blanco; Trinitario Pina; Carlos González-Juanatey; Javier Llorca; Miguel A González-Gay
Journal:  Biomed Res Int       Date:  2014-03-18       Impact factor: 3.411

4.  IGF-1 and ADMA levels are inversely correlated in nondiabetic ankylosing spondylitis patients undergoing anti-TNF-alpha therapy.

Authors:  Fernanda Genre; Raquel López-Mejías; Javier Rueda-Gotor; José A Miranda-Filloy; Begoña Ubilla; Aurelia Villar-Bonet; Beatriz Carnero-López; Inés Gómez-Acebo; Ricardo Blanco; Trinitario Pina; Carlos González-Juanatey; Javier Llorca; Miguel A González-Gay
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

5.  Differences in carotid atherosclerosis between patients with ankylosing spondylitis treated with tumor necrosis factor-α antagonists and healthy matched controls.

Authors:  Enrico Maria Zardi; Maria Elena Pipita; Chiara Giorgi; Domenico Lichinchi; Domenico Maria Zardi; Antonella Afeltra
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

6.  Retinol binding protein 4 concentrations relate to enhanced atherosclerosis in obese patients with rheumatoid arthritis.

Authors:  Patrick H Dessein; Linda Tsang; Gavin R Norton; Angela J Woodiwiss; Ahmed Solomon
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

Review 7.  Cardiovascular involvement in autoimmune diseases.

Authors:  Jenny Amaya-Amaya; Laura Montoya-Sánchez; Adriana Rojas-Villarraga
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

8.  Patients with ankylosing spondylitis and low disease activity because of anti-TNF-alpha therapy have higher TRAIL levels than controls: a potential compensatory effect.

Authors:  Fernanda Genre; Raquel López-Mejías; Javier Rueda-Gotor; José A Miranda-Filloy; Begoña Ubilla; Beatriz Carnero-López; Natalia Palmou-Fontana; Inés Gómez-Acebo; Ricardo Blanco; Trinitario Pina; Rodrigo Ochoa; Carlos González-Juanatey; Javier Llorca; Miguel A González-Gay
Journal:  Mediators Inflamm       Date:  2014-05-21       Impact factor: 4.711

9.  Subclinical atherosclerosis: A hidden threat for patients with ankylosing spondylitis.

Authors:  Wafa Hamdi; Kaouther Maatallah
Journal:  Anatol J Cardiol       Date:  2019-09       Impact factor: 1.596

10.  Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study.

Authors:  Jialing Wu; Xinyu Wu; Zena Chen; Qing Lv; Mingcan Yang; Xuqi Zheng; Qiuxia Li; Yanli Zhang; Qiujing Wei; Shuangyan Cao; Xiaomin Li; Jun Qi; Minjing Zhao; Zetao Liao; Zhiming Lin; Jieruo Gu
Journal:  Front Pharmacol       Date:  2020-03-10       Impact factor: 5.810
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.